Óleo de Cannabis de amplo espectro alivia sintomas comportamentais tipodepressivo e tipo-ansioso em camundongos expostos a eventos traumáticos
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Posttraumatic stress disorder (PTSD) is a psychiatric condition that presents a broad range
of symptoms and shares phenotypic similarities with anxiety and depression. Refractory
PTSD affects 10–30% of patients, underscoring the necessity for alternative
pharmacotherapy. The emerging understanding of the involvement of the
endocannabinoid system (ECS) in emotional processes has prompted exploration into the
therapeutic potential of Cannabis. Therefore, this study aimed to assess the therapeutic
effects of broad-spectrum Cannabis oil on anxiety- and depressive-like behaviors induced
by combined stressors. Additionally, the study investigated the impact of the oil on central
cannabinoid receptor 1 and serum levels of cytokines, chemokines, and growth factors.
Mice were randomly assigned to five groups (vehicle, fluoxetine, and Cannabis oil (0.1,
1, 3, and 10 mg/kg, oral dose) and subjected to acute restraint and chronic unpredictable
stress. They were then behaviorally evaluated using the elevated plus-maze test (EPMT),
forced swimming test (FST), splash test (ST), and open field test (OFT). The tetrad
cannabinoid assay assessed the central effects of the oil, while serum biomarker levels
were measured using a multiplex bead-based assay. Cannabis oil (0.1 mg/kg, p.o.)
significantly decreased anxiety-like behavior in the EPMT under acute restraint stress (p
< 0.05) compared to the vehicle. Moreover, Cannabis oil significantly reversed despair
and anhedonic-like behaviors in the FST (p < 0.05) and ST (p < 0.05), respectively, in
chronically stressed mice compared to the vehicle. Additionally, therapy with Cannabis
oil, compared to the vehicle, did not induce cannabinoid-tetrad effects (p < 0.0001); it
downregulated granulocyte-macrophage colony-stimulating factor (GM-CSF; p < 0.01)
and advanced glycation end-products (RAGE; p < 0.0001), and upregulated vascular
endothelial growth factor (VEGF; p < 0.01) serum levels. Collectively, our data suggest
the potential of broad-spectrum Cannabis oil to ameliorate symptoms related to anxiety
and depression resulting from traumatic events.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

